Literature DB >> 26341699

Next generation exome sequencing of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1 reveals different lineages.

Timon Vandamme1, Matthias Beyens2, Marc Peeters3, Guy Van Camp4, Ken Op de Beeck2.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26341699     DOI: 10.1016/j.cancergen.2015.07.003

Source DB:  PubMed          Journal:  Cancer Genet


× No keyword cloud information.
  6 in total

Review 1.  Clinical applications of (epi)genetics in gastroenteropancreatic neuroendocrine neoplasms: Moving towards liquid biopsies.

Authors:  Gitta Boons; Timon Vandamme; Marc Peeters; Guy Van Camp; Ken Op de Beeck
Journal:  Rev Endocr Metab Disord       Date:  2019-09       Impact factor: 6.514

2.  The link between menin and pleiotrophin in the tumor biology of pancreatic neuroendocrine neoplasms.

Authors:  Liping He; Steeve Boulant; Megan Stanifer; Cuncai Guo; Anna Nießen; Mingyi Chen; Klaus Felix; Frank Bergmann; Oliver Strobel; Simon Schimmack
Journal:  Cancer Sci       Date:  2022-03-08       Impact factor: 6.518

3.  Epigenetic pathway inhibitors represent potential drugs for treating pancreatic and bronchial neuroendocrine tumors.

Authors:  K E Lines; M Stevenson; P Filippakopoulos; S Müller; H E Lockstone; B Wright; S Grozinsky-Glasberg; A B Grossman; S Knapp; D Buck; C Bountra; R V Thakker
Journal:  Oncogenesis       Date:  2017-05-15       Impact factor: 7.485

4.  Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors in vitro: Antitumoral Effects.

Authors:  Xi-Feng Jin; Gerald Spoettl; Julian Maurer; Svenja Nölting; Christoph Josef Auernhammer
Journal:  Cancers (Basel)       Date:  2020-02-04       Impact factor: 6.639

5.  Ex Vivo Modeling of Human Neuroendocrine Tumors in Tissue Surrogates.

Authors:  Brendon Herring; Samuel Jang; Jason Whitt; Kayla Goliwas; Zviadi Aburjania; Vikas Dudeja; Bin Ren; Joel Berry; James Bibb; Andra Frost; Herbert Chen; John Bart Rose; Renata Jaskula-Sztul
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-23       Impact factor: 5.555

6.  A growth model of neuroendocrine tumor surrogates and the efficacy of a novel somatostatin-receptor-guided antibody-drug conjugate: Perspectives on clinical response?

Authors:  Brendon Herring; Jason Whitt; Tolulope Aweda; Jianfa Ou; Rachael Guenter; Suzanne Lapi; Joel Berry; Herbert Chen; Xiaoguang Liu; J Bart Rose; Renata Jaskula-Sztul
Journal:  Surgery       Date:  2019-09-19       Impact factor: 3.982

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.